Trials / NCT03998384
A New Treatment of Retinitis Pigmentosa
Status unknown N/A Other
- Sponsor
- Aier School of Ophthalmology, Central South University
- Treatment
- retrobulbar injection of autoserum; retrobulbar injection of placebo
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to 60 Years
- Enrollment
- 30 participants
- Started
- 2020-01-01
- Main results expected
- 2022-12-31
- Results posted
- Not yet
- Record last updated
- 2019-06-26
What the study is testing
This study is designed to assess and to evaluate the therapeutic effect of retrobulbar injection of autoserum in the treatment of retinitis pigmentosa.
Where it runs
No sites listed yet.